Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01879085
Title Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Acronym GemTax
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hussein Tawbi
Age Groups: adult
Covered Countries USA

No variant requirements are available.